| Name | cyclin D1 (PRAD1: parathyroid adenomatosis 1) |
| Symbol | CCND1 |
| Aliases | BCL1; PRAD1; U21B31; D11S287E; B-cell CLL/lymphoma 1; G1/S-specific cyclin D1 |
| Gene Product | |
| Category | - Amplification in Prostate cancer
|
| UniGene | Hs.82932 |
| OMIM | 168461 |
| Locus | 595 |
| Summary | The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. |
| Expression | | EST (702 ESTs, 241 libraries) |
| Tissue ? |
Frequency ? |
Count ? |
| adrenal gland (1/15) |  | 1/17521 |
| blood (1/27) | | 1/40686 |
| bone (4/13) | | 15/26211 |
| brain (17/204) | | 49/362011 |
| cervix (1/7) | | 4/28115 |
| colon (30/853) | | 78/165626 |
| embryo (2/19) | | 6/37976 |
| eye (8/33) | | 19/93836 |
| foreskin (1/4) | | 13/20040 |
| germ cell (3/7) | | 4/57383 |
| head and neck (18/990) | | 37/79796 |
| heart (3/22) | | 16/55494 |
| intestine (1/4) | | 3/11528 |
| kidney (7/86) | | 30/132968 |
| liver (2/38) | | 6/46472 |
| lung (17/312) | | 31/245386 |
| lymph node (1/5) | | 1/548 |
| muscle (1/21) | | 2/71297 |
| nervous (2/475) | | 3/43438 |
| oral cavity (2/18) | | 3/44567 |
| ovary (7/144) | | 12/81880 |
| pancreas (10/33) | | 34/117255 |
| parathyroid (1/4) | | 1/19377 |
| placenta (7/342) | | 31/157762 |
| prostate (8/291) |  | 26/109871 |
| skin (8/31) | | 59/100815 |
| stomach (11/312) | | 36/129930 |
| testis (1/171) | | 3/117531 |
| thyroid (2/24) | | 3/6853 |
| uncharacterized tissue (53/1773) | | 153/713325 |
| uterus (8/212) | | 19/155110 |
|
| SAGE (7431711 tags, 150 libraries) |
| Tissue ? |
Frequency ? |
Count ? |
| brain (15/19) | | 27/1450830 |
| cerebellum (1/1) | | 3/102560 |
| colon (6/8) | | 9/491270 |
| eye (6/6) | | 16/720047 |
| foreskin (1/2) | | 1/9497 |
| heart (1/1) | | 1/84357 |
| kidney (1/2) | | 2/41857 |
| liver (1/1) | | 16/133722 |
| lung (1/1) | | 2/178286 |
| mammary gland (13/19) | | 61/1127569 |
| muscle (1/2) | | 2/107750 |
| ovary (7/10) | | 22/366285 |
| pancreas (1/8) | | 1/35750 |
| prostate (9/13) | | 13/649791 |
| skin (5/7) | | 51/96092 |
| stomach (3/3) | | 9/443499 |
| uncharacterized tissue (17/22) | | 69/1095215 |
| vascular (3/3) | | 7/297334 |
|
|
| SNP | rs649392 (G/A:intron); rs647451 (T/C:intron); rs2510467 (G/A:intron); rs2062445 (A/C:mrna-utr); rs1051357 (C/A:mrna-utr); rs678653 (C/G:mrna-utr); rs7177 (A/G:mrna-utr); rs602652 (G/A/C:intron); rs616294 (A/G:intron); rs954618 (C/T:locus-region); rs1050971 (A/G:coding-nonsyn); rs603965 (G/A:coding-nonsyn); rs3017616 (C/G:intron); rs646056 (G/C:intron); rs586459 (G/C:intron); rs2510607 (G/A:mrna-utr); rs1352075 (C/T:intron); rs2930976 (T/G:intron); rs1944129 (A/G:locus-region); rs1051062 (T/A:mrna-utr); rs2220247 (G/T:coding-nonsyn); |
| Evidence | Amplification in Prostate cancer
|
